Hannover Rück, DE0008402215

Hannover Rück stock reacts to fresh Buy ratings and chart setback

Published on 09/20/2026 at 14:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hannover Rück stock slipped to around EUR 252 on September 18, 2026 after a 50-day moving average sell signal on Xetra. At the same time, analysts at DZ Bank and Jefferies reiterated Buy ratings, underpinned by multi-billion euro reinsurance revenues.

Drohnenaufnahme eines Hurrikans über Küstenstadt mit sichtbarem Auge der Sturmformation
Fotorealistisches Luftbild eines Hurrikans über einer Küstenstadt – ein kraftvolles Motiv für die globale Naturgefahren-Expertise der Hannover Rück SE (ISIN DE0008402215). Die Spiralform des Sturms symbolisiert das Kerngeschäft der Rückversicherung, Illustration mit AI erstellt.

Hannover Rück stock (ISIN DE0008402215) recently traded around EUR 252 on Xetra after a technical setback on September 18, 2026, when the 50-day moving average was crossed to the downside and the shares fell about 1.1 percent to EUR 252.40 in the session.

Technical signal meets strong business scale

According to finanzen.net, a down signal was triggered in the Hannover Rück chart on September 18, 2026 at 16:00 when the 50-day moving average was crossed from above, and the share price in the Xetra session moved lower by about 1.1 percent to EUR 252.40.

The same analysis notes a current quote of EUR 251.80 for Hannover Rück with a decline of EUR 2.00 or 0.79 percent versus the previous reference value, underscoring that the stock is consolidating after a strong run while staying well supported by its reinsurance franchise.

Scale of the reinsurance business

As Simply Wall St outlines in an overview dated as at September 2026, Hannover Rück is a global reinsurer that backs property, casualty, life and health risks, including credit and political risk covers that support global trade, and it generates about EUR 16.9 billion of revenue from Property and Casualty Reinsurance and EUR 7.8 billion from Life and Health Reinsurance.

In the same piece, Hannover Rück is described as having a market capitalization of about EUR 30.4 billion, highlighting the companys significant scale compared with other insurance and reinsurance peers and providing an anchor for investors assessing valuation against earnings and premium growth.

Analyst stance supports the stock

The technical consolidation comes against a supportive analyst backdrop. According to the analyst overview embedded in the Hannover Rück chart article on finanzen.net, DZ Bank issued a Kaufen (Buy) rating for Hannover Rück on September 18, 2026, while Jefferies and Berenberg reiterated Buy recommendations on September 9, 2026 and September 8, 2026 respectively, and Barclays maintained an Underweight view on September 4, 2026.

For retail investors, this mix of several Buy ratings alongside one Underweight call underscores that the market sees solid earnings and margin potential, even as some houses remain cautious about valuation or cycle risks in the reinsurance sector.

Trade-risk theme adds a strategic angle

The trade-risk and political-risk backdrop also feeds into the investment case. As Simply Wall St explains, Hannover Rücks balance sheet quietly underpins the credit and political risk insurance policies exporters use when tariffs and global trade rules become more volatile, and the analysis highlights that accelerating premium growth, diversified specialty expansion and strong reserve flexibility position Hannover Rück for potential outperformance in both earnings and long-term margin stability.

For long-term shareholders, the key question is how pressures in reserves and pricing assumptions feed through to margins, but the current revenue scale of roughly EUR 24.7 billion across the two main segments and the EUR 30.4 billion market capitalization provide a quantitative framework for assessing that margin trajectory.

Stock level and investor takeaway

With the recent price around EUR 251.80 on Xetra and a short-term decline of about 0.79 percent versus the prior reference level as of September 18, 2026, Hannover Rück stock remains below its latest local peak yet clearly supported by multi-billion euro reinsurance revenues and a set of fresh Buy ratings from houses such as DZ Bank, Jefferies and Berenberg.

Hannover Rück stock key data

  • Company: Hannover Rück SE
  • ISIN: DE0008402215
  • WKN: 840221
  • Ticker: HNR1
  • Trading venue: Xetra
  • Price (as of September 18, 2026): 251.80 EUR
  • Market capitalization: 30.40 billion EUR (as of September 2026)
  • Sector / Industry: Insurance / Reinsurance
  • Index membership: DAX

More news and analyses on Hannover Rück stock

Disclaimer...

en | DE0008402215 | HANNOVER RüCK | boerse | 70137630 | bgmi